Mutual Funds
Baroda BNP Paribas Health and Wellness Fund-Reg(G)
Equity  |   Very High  |   Equity - Sectoral Fund - Pharma & Health Care
10.69   -0.05
NAV(₹) as on 14/8/2026 		-0.45%
  1D 		8.54%
  1Y 		   -
  3Y 		   -
  5Y
Baroda BNP Paribas Health and Wellness Fund-Reg(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio:
2.78 		Launch Date:
27 Jun 2025
Exit Load:
NIL upto 10% of units and 1% for remaining units on or before 1Y, Nil after 1Y 		AUM:
₹ 519.48 Crs
Lock-in:
Nil 		Investing Style:
Large Growth
Portfolio Price To Book Value:
10.14 		Min. Investment:
SIP : ₹ 500.00
Lumpsum : ₹ 1,000.00
Scheme Benchmark:
NA
Fund Manager:
Sanjay Chawla ,Ankeet Pandya

FUND OBJECTIVE

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.

LATEST ASSET & PORTFOLIO ALLOCATION Others Equity
as on 31/7/2026 3.39 % 96.61 %
TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.
8.82 %

Torrent Pharmaceuticals Ltd.
8.58 %

Divi's Laboratories Ltd.
6.66 %

Lupin Ltd.
6.46 %

Ipca Laboratories Ltd.
5.72 %

Apollo Hospitals Enterprise Ltd.
5.35 %

Laurus Labs Ltd.
5.24 %

Fortis Healthcare Ltd.
4.55 %

Astrazeneca Pharma India Ltd.
4.05 %

Glenmark Pharmaceuticals Ltd.
3.44 %

See All Holding
ALLOCATION BY MARKET CAP (Equity)
ALLOCATION BY RATING (Debt & Others)

No Data

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs
72.13 %

Hospital & Healthcare Servic
19.70 %

Finance - Others
2.27 %

IT - Software
1.42 %

Retailing
1.09 %

See All Sectors
PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year 2025-26
NAV (31/3/2026) 9.10
Net Assets (Rs Crores) 51,519.31
Scheme Returns(%)(Absolute) -8.96
B'mark Returns(%)(Absolute) NA
Category Rank 98/120
RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details Inception Date Aum(₹ Crs) 1Y 3Y 5Y Since Inception
MDB Logo
HDFC Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  21.42   +-0.01  
4/10/2023 ₹ 2,939.98 23.63% - - 30.64%
MDB Logo
WOC Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  16.78   +-0.05  
6/2/2024 ₹ 824.9 19.70% - - 22.80%
MDB Logo
PGIM India Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  12.14   +-0.03  
6/12/2024 ₹ 111.64 21.89% - - 12.18%
MDB Logo
Bajaj Finserv Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  11.65   +-0.09  
27/12/2024 ₹ 376.77 19.42% - - 9.83%
MDB Logo
Baroda BNP Paribas Health and Wellness Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  10.69   +-0.05  
27/6/2025 ₹ 519.48 8.54% - - 6.08%
MDB Logo
Bandhan Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  11.24   +-0.01  
28/11/2025 ₹ 319.48 - - - 12.37%
MDB Logo
Kotak Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  16.66   +0.03  
11/12/2023 ₹ 682.39 22.53% - - 21.02%
MDB Logo
ITI Pharma & Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  18.03   +-0.06  
8/11/2021 ₹ 262.84 10.34% 18.08% - 13.16%
MDB Logo
Nippon India Pharma Fund(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  573.15   +-1.29  
5/6/2004 ₹ 9,279.11 10.32% 18.10% 13.38% 20.00%
MDB Logo
Tata India Pharma & Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  33.63   +-0.05  
28/12/2015 ₹ 1,541.42 8.37% 18.59% 13.82% 12.08%